Se-In Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Se-In Lee has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Jinsoo Seo
Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea
2 shared publications Sukhee Cho
Department of Brain Sciences, DGIST, Daegu, Republic of Korea
2 shared publicationsBuyun Kim
Korean Medicine-Application Center, Korea Institute of Oriental Medicine, Daegu, South Korea
1 shared publicationChang Geon Chung
Department of Neurology, Baylor College of Medicine, Houston, USA
1 shared publication- Daehee Hwang
School of Biological Sciences, Seoul National University, Seoul, Republic of Korea
1 shared publication - Do Young Hyeon
School of Biological Sciences, Seoul National University, Seoul, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by Springer Nature in Nature Communications
Failure of TSPO-dependent metabolic compensation marks the loss of mitochondrial bioenergetic adaptation in parkin-deficient neurons
Neurons require mitochondrial bioenergetic flexibility to withstand chronic mitochondrial quality control failure, yet the compensatory safeguards that preserve mitochondrial functional output during neurodegenerative progression remain unclear. Here, using parkin- deficient fly models, we identify an early mitochondrial metabolic signature characterized by reduced pyruvate and increased glutamate and α-ketoglutarate. Substrate-specific mitochondrial respiration and ATP assays showed impaired pyruvate-supported bioenergetic capacity but preserved glutamate-supported bioenergetic capacity, supporting a transient glutamate-linked compensatory state before neurodegenerative deterioration. We identify neuronal TSPO upregulation as an adaptive compensatory mechanism that sustains glutamate-supported mitochondrial bioenergetic capacity under parkin -deficient conditions. In human iPSC-derived neurons, parkin deficiency was similarly associated with TSPO upregulation, and TSPO modulation altered neuronal vulnerability. TSPO induction was controlled by JNK-Jun/Nrf2 signaling, whose age-associated attenuation compromised compensation and accelerated neurodegeneration. Thus, loss of TSPO-dependent glutamate-linked bioenergetic compensation marks the transition from mitochondrial adaptation to neurodegenerative deterioration under parkin -deficient conditions.
- 13 November 2026
- Published by Springer Nature in Nature Communications
Open AccessFailure of TSPO-dependent metabolic compensation marks the loss of mitochondrial bioenergetic adaptation in parkin-deficient neurons
Neurons require mitochondrial bioenergetic flexibility to withstand chronic mitochondrial quality control failure, yet the compensatory safeguards that preserve mitochondrial functional output during neurodegenerative progression remain unclear. Here, using parkin- deficient fly models, we identify an early mitochondrial metabolic signature characterized by reduced pyruvate and increased glutamate and α-ketoglutarate. Substrate-specific mitochondrial respiration and ATP assays showed impaired pyruvate-supported bioenergetic capacity but preserved glutamate-supported bioenergetic capacity, supporting a transient glutamate-linked compensatory state before neurodegenerative deterioration. We identify neuronal TSPO upregulation as an adaptive compensatory mechanism that sustains glutamate-supported mitochondrial bioenergetic capacity under parkin -deficient conditions. In human iPSC-derived neurons, parkin deficiency was similarly associated with TSPO upregulation, and TSPO modulation altered neuronal vulnerability. TSPO induction was controlled by JNK-Jun/Nrf2 signaling, whose age-associated attenuation compromised compensation and accelerated neurodegeneration. Thus, loss of TSPO-dependent glutamate-linked bioenergetic compensation marks the transition from mitochondrial adaptation to neurodegenerative deterioration under parkin -deficient conditions.
- Open Access
- 14 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Astrocyte priming enhances microglial Aβ clearance and is compromised by APOE4
The innate immune system can develop a form of memory called priming, where prior exposure to a stimulus enhances subsequent responses. While well-characterized in peripheral immunity, its function in brain-resident cells such as astrocytes under non-disease conditions remains unclear. Here we show that human astrocytes derived from the induced pluripotent stem cells of healthy female donors, but not microglia, acquire a primed state following transient immune stimulations. Upon subsequent exposure to amyloid-β (Aβ), these astrocytes secrete elevated levels of cytokines and promote microglial Aβ uptake. In contrast, astrocytes carrying the Alzheimer’s disease (AD) risk allele APOE4 exhibit reduced priming and fail to support microglial phagocytosis. These findings are validated in astrocyte-microglial co-cultures, cerebral organoids, and male mice, where astrocyte priming enhances Aβ clearance in an APOE4-sensitive manner. Our findings identify astrocytic immune memory as a modulator of microglial function and Aβ pathology, providing insights into how early protective responses in AD may be disrupted by genetic risk factors.
- 14 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Open AccessAstrocyte priming enhances microglial Aβ clearance and is compromised by APOE4
The innate immune system can develop a form of memory called priming, where prior exposure to a stimulus enhances subsequent responses. While well-characterized in peripheral immunity, its function in brain-resident cells such as astrocytes under non-disease conditions remains unclear. Here we show that human astrocytes derived from the induced pluripotent stem cells of healthy female donors, but not microglia, acquire a primed state following transient immune stimulations. Upon subsequent exposure to amyloid-β (Aβ), these astrocytes secrete elevated levels of cytokines and promote microglial Aβ uptake. In contrast, astrocytes carrying the Alzheimer’s disease (AD) risk allele APOE4 exhibit reduced priming and fail to support microglial phagocytosis. These findings are validated in astrocyte-microglial co-cultures, cerebral organoids, and male mice, where astrocyte priming enhances Aβ clearance in an APOE4-sensitive manner. Our findings identify astrocytic immune memory as a modulator of microglial function and Aβ pathology, providing insights into how early protective responses in AD may be disrupted by genetic risk factors.